StockNews.com started coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a report published on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Price Performance XBiotech stock opened at $4.22 on Monday. The firm has a fifty day simple moving average of $4.19 and a two-hundred day simple moving […]

Related Keywords

, Xbiotech Inc , Ea Series , Xbiotech Company Profile , Dimensional Fund Advisors , Renaissance Technologies , Millennium Management , Free Report , Fund Advisors , Get Free Report , True Human , Xbiotech , Nasdaq Xbit , Taxbit , Medical , Initiated Coverage , Stocknews Com ,